Gleb Sagitov wasn’t sure he wanted to go into pharmaceuticals. But Regeneron, the Tarrytown-based biotechnology company that develops, manufactures, and markets life-saving medicines, has a prescription for go-getters like Sagitov: opportunity. “A lot of my success is due to the environment,” says Sagitov. “I love the company; I love the culture.” As manager of commercial analytics, Sagitov identifies markets and opportunities for drugs that treat eye disease, colorectal cancer, heart disease, and rare inflammatory conditions, among others. He started as a lab intern and was later hired in the finance group. The bosses liked Sagitov’s outside-the-box thinking and quickly learned he was a problem-solver. Sagitov loves that he is at the intersection of science and business. A common question—and primary motivator—for him and his colleagues is, “How do we most effectively get life-saving medicines and treatments to those who need them?” What, asks Sagitov, “can we do to get drugs commercialized and to the patients? We speak a common language.”
• Born in the Soviet Union, Sagitov moved to the US when he was 3. He went to Horace Greeley High School in Chappaqua and credits his teachers there with fostering intellectual curiosity. “It’s a small community with a global perspective,”he says.
• Sagitov holds a degree in economics from the University of Michigan–Ann Arbor and is pursuing an MBA at NYU’s Stern School of Business.